Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) P/S ratio
As of 5 November 2026, Merit Medical Systems, Inc. (MMSI) trades at a P/S ratio of 3.3×. Over the past ten years it has ranged from 1.2× (October 2019) to 4.7× (January 2025); the current reading is higher than 59% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and in line with the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 3.4× | (17.14%) |
| FY2024 | 4.2× | 18.65% |
| FY2023 | 3.5× | 1.85% |
| FY2022 | 3.4× | 5.55% |
| FY2021 | 3.3× | 1.95% |
| FY2020 | 3.2× | 84.72% |
| FY2019 | 1.7× | (47.70%) |
| FY2018 | 3.3× | 13.16% |
| FY2017 | 2.9× | 51.56% |
| FY2016 | 1.9× | 27.60% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 3.2× | 22.14% |
| Jun 2026 | 2.6× | (1.45%) |
| Mar 2026 | 2.7× | (22.68%) |
| Dec 2025 | 3.4× | 3.04% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.3× |
| NVST Envista Holdings Corporation compare | 1.4× |
| MMED MiniMed Group, Inc. compare | 1.7× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.5× |
| TFX Teleflex Incorporated compare | 2.9× |
| MMSI Merit Medical Systems, Inc. | 3.3× |
| ATRC AtriCure, Inc. compare | 5.0× |
| PLSE Pulse Biosciences, Inc compare | 2,559× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on MMSI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement